Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey
Choosing between bmiMD and TRT Nation for GLP-1 weight loss medication? Both are popular providers, but they differ in pricing, medication options, and service features.
bmiMD offers both semaglutide and tirzepatide at $129/month with a rating of 8/10. TRT Nation offers tirzepatide at $219/month with a 7.5/10 rating.
The price difference of $90/month is significant - bmiMD is the more budget-friendly option, while TRT Nation positions itself as a premium service.
After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.
| Feature | bmiMD | TRT Nation |
|---|---|---|
| Monthly Price | $129 | $219 |
| Rating | 8/10 | 7.5/10 |
| Medications | semaglutide, tirzepatide, metformin | tirzepatide |
| Insurance Accepted | No | No |
| Support Hours | 24/7 clinician access claimed | Monday to Friday, 10am-5pm EST |
| Live Chat | No | No |
| Free Shipping | Yes | Yes |
| Shipping Speed | Free shipping on subscription orders; timeframe not published | Free, discreet shipping direct to your door |
| Mobile App | No | No |
| Dedicated Coach | Not included | Not included |
| Follow-up Frequency | 24/7 clinician access with refills delivered on subscription | Ongoing medical consultations and provider check-ins included |
| Money-back Guarantee | 100% refund if you are not approved for treatment; otherwise all sales are final once the prescription reaches the pharmacy | None published |
| Cancellation Policy | Cancel or pause from your account any time, but a $50 non-refundable fee applies after intake approval and there are no refunds for partially used periods | Three-month minimum purchase on the tirzepatide programme |

